BMO raises Meta target price to $685 from $580
META•BMO raised its target price for Meta to $685 from $580.
Related News
CareDx study links elevated AlloSure Kidney levels to nearly threefold higher risk of adverse graft outcomes
CDNA•
PSEG: BMO cuts target price to $77 from $79
PEG•
Lantronix publishes update to financial calendar
LTRX•
Las Vegas Sands: Deutsche Bank cuts target price to $51 from $56
LVS•
Sagimet doses first patient in U.S. Phase 3 trial of denifanstat for acne
SGMT•